These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Looking back to the future of psychopharmacology. Hirshbein L J Nerv Ment Dis; 2012 Dec; 200(12):1109-12. PubMed ID: 23183368 [TBL] [Abstract][Full Text] [Related]
36. [A new trend in psychopharmacology: designed psychopharmaceuticals with fewer adverse effects as a result of development of molecular biology?]. Wilhelmson B Lakartidningen; 1992 Apr; 89(15):1316-20. PubMed ID: 1315893 [No Abstract] [Full Text] [Related]
37. Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs. Mercolini L; Saracino MA; Protti M Bioanalysis; 2015; 7(15):1925-42. PubMed ID: 26295991 [TBL] [Abstract][Full Text] [Related]
38. Needs and opportunities for innovation in psychopharmacology. Stahl SM J R Soc Med; 1987 Jul; 80(7):413-7. PubMed ID: 3656311 [No Abstract] [Full Text] [Related]
39. [Various current problems in clinical psychopharmacology]. Smulevich AB; Panteleeva GP Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1345-51. PubMed ID: 6637291 [TBL] [Abstract][Full Text] [Related]
40. The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993. Haigler HJ Psychopharmacol Bull; 1994; 30(1):19-22. PubMed ID: 7972624 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]